ARTICLE | Company News
AGIX falls after reacquiring AGI-1067
October 5, 2001 7:00 AM UTC
AtheroGenics (AGIX) was off $1.39 (34%) to $2.71 on Friday. On Thursday after market close, the company said it reacquired rights to cardiovascular compound AGI-1067, an oral small molecule that block...